Vice President, MEG Oncology Head, Cross-Portfolio Excellence & MEG Alliances

Job description preview

From Bristol Myers Squibb’s original posting

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. Key Responsibilities • Strategic Portfolio Leadership: Own the 3-year strategic MEG plan for Oncology (solid tumor and hematology) — the largest portfolio in MEG, comprising ~60% of the overall Book of Work — setting direction, priorities, and trade-offs across the full portfolio of studies in partnership with the worldwide TA (WWTA) leadership. • Integrated Evidence Planning: Set the strategic framework for, and provide executive oversight of the IEPs for Oncology assets/indications across both solid tumor and hematology, ensuring alignment with unmet medical needs and enterprise business priorities, in partnership with WWTA teams, HEOR,…